ARTICLE | Company News
Bind Therapeutics, Merck deal
November 10, 2014 8:00 AM UTC
The companies partnered to discover and develop nanomedicines using Bind's Medicinal Nanoengineering platform to create targeted Accurins based on payloads from Merck's preclinical oncology portfolio....